Abstract 2953: CS5006: A novel integrin β4-targeted antibody-drug conjugate (ADC) with robust antitumor activity in preclinical studies
Chuan Wang(Qilu Hospital of Shandong University), Jianxin Yang(Ascepion Pharmaceuticals (China)), Jingyu Sun(Shanghai East Hospital), Xueqin Dai(Ascepion Pharmaceuticals (China)), Yi Sun(Ascepion Pharmaceuticals (China)), Yilin Huo(Ascepion Pharmaceuticals (China)), Ning Zhang(Ascepion Pharmaceuticals (China)), Yamin Wang(Ascepion Pharmaceuticals (China)), Xuelian Liu(Ascepion Pharmaceuticals (China)), Yongli Yang(Southwest Forestry University), Xinling Zhang(Qingdao University), Yongwang Li(Shenzhen Third People’s Hospital), Fei Ma(Ascepion Pharmaceuticals (China)), Mengyao Zhu(Ascepion Pharmaceuticals (China))
Cited by 0
Related Papers
Design and Mechanisms of Asymmetric Supercapacitors
|Chemical Reviews|2018|3.6k
Crafting Mussel‐Inspired Metal Nanoparticle‐Decorated Ultrathin Graphitic Carbon Nitride for the Degradation of Chemical Pollutants and Production of Chemical Resources
|Advanced Materials|2019|422
Bridging the Gap between Reality and Ideal in Chemical Vapor Deposition Growth of Graphene
|Chemical Reviews|2018|396
Towards super-clean graphene
|Nature Communications|2019|217